• About us
• Contact

Advertisement

Organisation › Details

Bayer LifeHub UK (Reading)

In October 2019 Bayer launched LifeHub UK to accelerate and optimize disease detection and data-driven drug discovery by developing artificial-intelligence-enabled imaging solutions. The new hub is the seventh pillar of Bayer’s global network of LifeHubs designed to accelerate the co-exploration and development of pioneering solutions to solve global challenges in health and nutrition. AI-enabled imaging solutions in focus at LifeHub UK As a first step, Bayer’s LifeHub UK will focus on the development of AI-enabled radiology solutions by building on its longstanding knowledge and expertise in the medical imaging field. Clinical AI company Sensyne Health – after sealing a collaboration agreement with Bayer earlier this year – is one of the first companies to move into LifeHub UK. In addition to the already-established collaboration, both parties intend to conduct joint R&D activities for the development of AI-enabled imaging solutions. *

 

	Start	2019-10-10 established
	Group	Bayer (Group)
	Industry	LIFE SCIENCES
	Industry 2	business park management / science park management
	Region	Reading, Berkshire
	Country	United Kingdom (GB)
	City	n. a. Reading, Berkshire
		Address record changed: 2020-01-23
Basic data	Employees	n. a.
		* Document for »About Section«: Bayer AG. (10/10/19). "Press Release: Bayer Launches LifeHub UK Focused on Artificial Intelligence to Optimize Data-driven Drug discovery and Disease Diagnosis". Leverkusen & Reading.
		Record changed: 2023-07-10

Advertisement

More documents for Bayer (Group)

• [1] BenevolentAI Ltd.. (1/24/24). "Press Release: BenevolentAI Appoints Dr. Joerg Moeller as Chief Executive Officer". London....
• [2] Bicycle Therapeutics plc. (5/10/23). "Press Release: Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology". Berlin, Cambridge & Boston, MA....
• [3] Bayer AG. (2/13/23). "Press Release: Bayer Completes Acquisition of Blackford Analysis Ltd. [not intended for U.S. and UK Media]". Berlin....
• [4] Bayer AG. (1/18/23). "Press Release: Bayer Acquires Blackford Analysis Ltd. Bolstering the company’s Position in Digital Medical Imaging [not intended for U.S. and UK Media]". Berlin....
• [5] Bayer AG. (4/2122). "Press Release: Bayer Appoints Tara Frenkl as the New Head of Oncology Development at Its Oncology Strategic Business Unit". Berlin....
• [6] NuCana plc. (12/21/20). "Press Release: NuCana Appoints Andrew Kay as Board Chairman". Edinburgh....
• [7] Bayer Pharmaceuticals Corporation. (9/9/20). "Press Release: Bayer Completes Acquisition of the UK-based Biotech Company Kandy Therapeutics Ltd.". Whippany, NJ....
• [8] Recursion Pharmaceuticals, Inc.. (9/9/20). "Press Release: Recursion Secures $239 Million in Equity Financing to Advance Technology-Enabled Drug Discovery Platform and Pipeline". Salt Lake City, UT....
• [9] Bayer AG. (8/11/20). "Press Release: Bayer to Acquire UK-based Biotech Kandy Therapeutics Ltd. [Not intended for U.S. and UK Media]". Berlin....
• [10] Exact Therapeutics AS. (6/3/20). "Press Release: Norwegian Exact Therapeutics Appoints Dr. Rafiq Hasan as CEO"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.